Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Self-Management of Vaginal Pessaries: A Viable Alternative for Pelvic Organ P...
Treatment Effect Estimation with AI: The CURE Framework
Drug Discovery with AI: A Glimpse into the Future of Pharmaceuticals
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Managing Access to Medicines in the Future: Innovations and Strategies
Cancer Care and the Importance of AI in Furthering Oncology
The Relevance of AI in Mastering Polypharmacy Management
Managed Access of Dostarlimab: For Endometrial Cancer
Advancing Healthcare: The Role of Real-World Evidence in Decision-Making
An Update on The Economic Impact of Adult Immunisation
COPD Management: Evidence Report on Ensifentrine
A Cost-Effectiveness Analysis of Emicizumab Treatment in Non-Severe Haemophil...
« Previous
1
2
3
4
5
6
…
10
Next »